Karl Chalabala

Stock Analyst at UBS

(1.10)
# 3,747
Out of 5,072 analysts
9
Total ratings
33.33%
Success rate
-3.34%
Average return

Stocks Rated by Karl Chalabala

Amicus Therapeutics
May 2, 2025
Maintains: Buy
Price Target: $21$22
Current: $9.87
Upside: +122.90%
Southern Copper
Feb 23, 2023
Maintains: Sell
Price Target: $46$49
Current: $129.12
Upside: -62.35%
Comstock Resources
Aug 14, 2017
Maintains: Buy
Price Target: $14$12
Current: $25.14
Upside: -52.27%
Gulfport Energy
Aug 14, 2017
Maintains: Buy
Price Target: $21$18
Current: $211.98
Upside: -91.51%